by Michael Hiltzik The pharmaceutical industry’s all-out attack on President Joe Biden’s drug negotiation initiative for Medicare — comprising nine federal lawsuits (so far) and lots of heavy breathing by lobbyists — has just run into a major snag. That it came from a judge ...
The U.S. pays 50% more per capita for prescription drugs than Canada. Frustrated by this discrepancy, a handful of states in recent years have developed plans to import cheaper medications from across the border. Florida recently became the first state to get approval from the Food and Drug ...
The Inflation Reduction Act, passed last year, gave Medicare the authority to negotiate drug prices for the first time. The government will start with 10 medications, which were announced last month. Now it just needs to figure out how much they should cost. When Congress created ...
by Lisa Jarvis After months of speculation, the Centers for Medicare and Medicaid Services (known as CMS) has finally released the list of medicines that will be subject to the agency’s new price-negotiating powers. The list should give the public hope that — assuming legal ...
by Rekha Basu Ajit “Ayaan” Sharma, a skinny 11-year-old with dark eyes that gleam like headlights, bounces around a New Delhi home on the balls of his feet. He exudes an energetic spunk for a kid living with only one working lung — and that functioning at only 40% — because of ...
by Chris Stansbury The Biden administration seems to be a fan of doubling down on bad ideas. After adding more than $5 trillion to the national debt since taking office in 2021, the White House has teed-up a nearly $7 trillion budget proposal for 2024. The track record of fiscal ...